Product Information
HYDROMET 5 MG-1.5 MG/5 ML SOLN is a generic product labeled by Actavis Pharma, Inc., priced at $0.1031 per ML under NDC 00472103016. Its NADAC has been published 667 times since Nov 28, 2013.
FDA first approved this application on Jul 5, 1983. Its Orange Book therapeutic-equivalence code is AA.
Strength
1.5; 5 mg/5mL; mg/5mL
Manufacturer
Actavis Pharma, Inc.NDC
00472103016
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
HOMATROPINE METHYLBROMIDE; HYDROCODONE BITARTRATEApproval Type
Generic (ANDA)
FDA Application
ANDA088017FDA Approved
7/5/1983
TE Code
AA
On Market Since
9/30/2002
Pharmacological Classes
Price Statistics
The NADAC for HYDROMET 5 MG-1.5 MG/5 ML SOLN has been published 667 times since Nov 28, 2013, and over the history we have for it it has risen 6.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1031 per ML |
|---|---|
| All-time high | $0.1206 (Apr 13, 2016) |
| All-time low | $0.0399 (Nov 20, 2024) |
| 52-week high | $0.1031 |
| 52-week low | $0.0918 |
| Median price | $0.0943 |
| Average price | $0.0897 |
| Largest weekly change | +62.1% (Feb 21, 2024) |
| Weeks tracked | 667 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
+2.6%
6M
+5.2%
1Y
+8.5%
3Y
+85.2%
5Y
+13.6%
All
+6.6%
Last surveyed Sep 2, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the hydrocodone bitartrate and homatropine methylbromide market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Actavis Pharma, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
hydrocodone bitartrate and homatropine methylbromide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Opioid Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of HYDROMET 5 MG-1.5 MG/5 ML SOLN?
The current National Average Drug Acquisition Cost (NADAC) for HYDROMET 5 MG-1.5 MG/5 ML SOLN, manufactured by Actavis Pharma, Inc., is $0.1031 per ML (NDC 00472103016), effective Sep 2, 2026.
How has the price of HYDROMET 5 MG-1.5 MG/5 ML SOLN changed over time?
Over the history we have for it, the NADAC for HYDROMET 5 MG-1.5 MG/5 ML SOLN has risen 6.6%. It has been tracked across 667 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for HYDROMET 5 MG-1.5 MG/5 ML SOLN?
Since Nov 28, 2013, the NADAC for HYDROMET 5 MG-1.5 MG/5 ML SOLN has ranged from a low of $0.0399 (Nov 20, 2024) to a high of $0.1206 (Apr 13, 2016), with a median of $0.0943 per ML.
Are there cheaper alternatives to HYDROMET 5 MG-1.5 MG/5 ML SOLN?
No other NADAC-published product currently shares the active ingredient and strength of HYDROMET 5 MG-1.5 MG/5 ML SOLN in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures HYDROMET 5 MG-1.5 MG/5 ML SOLN?
HYDROMET 5 MG-1.5 MG/5 ML SOLN (NDC 00472103016) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.